IDiyas

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Jane Louise Grogan

USPTO Granted Patents = 12 

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 81(Granted Patents)


Company Filing History:

goldMedal11 out of 3,221 
 
Genentech, Inc.
 patents
silverMedal1 out of 98 
 
Genetech, Inc.
 patents

Years Active: 2011-2023

Loading Chart...
12 patents (USPTO):Explore Patents
1. 11739150 - Anti-CD8 antibodies and uses thereof (2023-08-29),
2. 11390678 - Compositions and methods for the treatment of immune related diseases (2022-07-19),
3. 10626174 - Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors (2020-04-21),
4. 10611836 - Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors (2020-04-07),
5. 10047158 - Anti-TIGIT antibodies and methods of use (2018-08-14),
6. 10017572 - Anti-tigit antibodies and methods of use (2018-07-10),
7. 9873740 - Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors (2018-01-23),
8. 9499596 - Compositions and methods for the treatment of immune related diseases (2016-11-22),
9. 8642740 - Antibodies to lymphotoxin-alpha (2014-02-04),
10. 8541552 - Antibodies to lymphotoxin-α (2013-09-24),
11. 8216807 - Antibodies to lymphotoxin-α (2012-07-10),
12. 7923011 - Antibodies to lymphotoxin-alpha (2011-04-12),

Sure, here is the article about inventor Jane Louise Grogan:

Title: Innovator Spotlight - Jane Louise Grogan: Driving Innovations in Biotechnology

Introduction:

Jane Louise Grogan, a prominent inventor based in San Francisco, CA, is a trailblazer in the field of biotechnology. With an impressive portfolio of 12 patents, she has made significant contributions to the development of novel therapies and diagnostic tools for immune-related diseases.

Latest Patents:

One of Jane's latest patents is on "Anti-CD8 antibodies and uses thereof." This groundbreaking invention includes antibodies that bind human CD8 without influencing the activation of CD8T cells. Additionally, Jane's patent covers methods for detecting CD8T cells in cancer patients and monitoring disease progression and treatment efficacy.

Another notable patent is on "Compositions and methods for the treatment of immune-related diseases." This patent focuses on innovative compositions and their applications in diagnosing and treating various immune-related disorders.

Career Highlights:

Jane Louise Grogan has a rich professional background, having worked at leading biotechnology companies such as Genentech, Inc. Through her tenure at Genentech, Inc. (corrected from Genetech, Inc.), she has spearheaded numerous research projects that have paved the way for groundbreaking discoveries in the field of biotechnology.

Collaborations:

During her career, Jane has collaborated with esteemed colleagues such as Dan L Eaton and Jason A Hackney. These collaborative efforts have led to the successful development and commercialization of innovative biotechnological solutions.

Conclusion:

In conclusion, Jane Louise Grogan stands as a beacon of innovation in the biotechnology sector. Her relentless pursuit of excellence and passion for advancing healthcare through cutting-edge inventions have cemented her legacy as a pioneering inventor in the field. We look forward to witnessing more revolutionary contributions from this extraordinary innovator.

If you need further information or have any specific requests, feel free to reach out.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…